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The C-type lectin receptor (CTLR), Clec4d (MCL, CLECSF8), is a member of the Dectin-2
cluster of CTLRs, which also includes the related receptors Mincle and Dectin-2. Like Min-
cle, Clec4d recognizes mycobacterial cord factor, trehalose dimycolate, and we recently
demonstrated its key role in anti-mycobacterial immunity in mouse and man. Here, we
characterized receptor expression in naı¨vemice, under inflammatory conditions, and dur-
ing Mycobacterium bovis BCG infection using newly generated monoclonal antibodies. In
naı¨ve mice, Clec4d was predominantly expressed on myeloid cells within the peritoneal
cavity, blood, and bone marrow. Unexpectedly, basal expression of Clec4d was very low
on leukocytes in the lung. However, receptor expression was significantly upregulated
on pulmonary myeloid cells during M. bovis BCG infection. Moreover, Clec4d expression
could be strongly induced in vitro and in vivo by various microbial stimuli, including TLR
agonists, but not exogenous cytokines. Notably, we show that Clec4d requires association
with the signaling adaptor FcRγ and Mincle, but not Dectin-2, for surface expression. In
addition, we provide evidence that Clec4d and Mincle, but not Dectin-2, are interdepen-
dently coregulated during inflammation and infection. These data show that Clec4d is an
inducible myeloid-expressed CTLR in mice, whose expression is tightly linked to that of
Mincle.
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Introduction
The Dectin-2 family of C-type lectin receptors (CTLRs) encoded
upstream of the murine and human NK gene cluster consists
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of CLECSF8 (Clec4d), Mincle (Clec4e), Dectin-2 (Clec4n), DCIR
(Clec4a), DCAR (Clec4b), and BDCA-2 (Clec4c). All these recep-
tors are type II transmembrane receptors possessing a single C-type
lectin-like domain (CTLD), a stalk and transmembrane region,
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and, with the exception of DCIR, a short cytoplasmic tail [1]. These
receptors recognize a diverse range of endogenous and exogenous
ligands, and can function as pattern recognition receptors for sev-
eral classes of pathogens including fungi, bacteria, and parasites,
driving both innate and adaptive immune responses [1].
Of interest here is Clec4d (also called macrophage C-type lectin
(MCL), Dectin-3, CLEC6, CLECSF8), a CTLR identified over 15
years ago in the Gordon laboratory following a screen of a murine
differential display library for macrophage-specific genes [2]. Sub-
sequent analysis of protein expression in human and rat, however,
has shown that Clec4d can also be expressed by other myeloid
cell types, including neutrophils and monocytes [3, 4]. Like Min-
cle and Dectin-2, surface expression of Clec4d requires associa-
tion with the signaling adaptor FcRγ, which also mediates down-
stream signaling through the Syk/CARD9 pathway [1, 5]. Unlike
the other Dectin-2 family members, however, intracellular reten-
tion of Clec4d, in the absence of adaptors, is mediated by the
C-type lectin domain and not the transmembrane region [3]. This
is likely to be due to the ability of Clec4d to form functional recep-
tor complexes with Dectin-2 and Mincle [6, 7]. In fact, Clec4d was
found to be required for the induction and surface expression of
Mincle [5, 7].
The CTLD of Clec4d lacks the conserved amino acids normally
associated with carbohydrate recognition and, unlike the other
Dectin-2 family receptors, is unable to recognize unconjugated
sugars [3]. However, Clec4d possesses a shallow hydrophobic
region on its surface, enabling it to bind glycolipids, including
mycobacterial cord factor (trehalose dimycolate, TDM) [5, 8].
We recently demonstrated that Clec4d plays a key role in anti-
mycobacterial host defense, acting as a nonopsonic receptor for
mycobacteria on pulmonary leukocytes [9]. Loss of this C-type
lectin receptor in mice resulted in exacerbated inflammation,
higher mycobacterial burdens, and increased mortality [9]. Fur-
thermore, a polymorphism of Clec4d in humans, which caused
reduced surface expression of the receptor, is associated with
increased susceptibility to pulmonary tuberculosis [9]. Given the
importance of the murine model for further study of this recep-
tor in anti-mycobacterial immunity, we describe here the charac-
terization of Clec4d expression during resting and inflammatory
conditions, and during infection with Mycobacterium bovis Bacil-
lus Calmette–Gue´rin (BCG) in the mouse. We have also further
investigated the codependent relationship of Clec4d expression
with Mincle and Dectin-2.
Results
Generation of anti-mClec4d monoclonal antibodies
To investigate expression of mClec4d, we generated and char-
acterized novel mABs specific for this receptor using two key-
hole limpet hemocyanin (KLH)-linked Clec4d peptides (P160 and
P134) located within unique regions of the extracellular domain
(Fig. 1A). Attempts using the intact CTLD of Clec4d did not gen-
erate specific mABs (data not shown). Rats were immunized with
the peptides and hybridomas generated and screened as described
in materials and methods. We selected four clones that bound
either BSA-conjugated Clec4d peptide by ELISA (Fig. 1B). All
clones detected a soluble chimeric protein containing the CTLD of
Clec4d fused to the Fc-portion of human IgG1, Clec4d-Fc [3], but
not the closely related Mincle-Fc [5], byWestern blot under reduc-
ing and nonreducing conditions (Fig. 1C). To assess the potential
of these clones to be used as blocking antibodies, we made use of
the Clec4d reporter cell system that induces GFP expression upon
stimulation with mycobacteria [5, 9]. We found that pretreat-
ment of the cells with the mAB clone 3A4 abolished reporter cell
activation induced by M. bovis BCG making it a potentially valu-
able tool for in vivo receptor blocking experiments in the future
(Fig. 1D). The 3A4 antibody further stained Clec4d but not Mincle
transduced NIH-3T3 fibroblast cells (Fig. 1E). To further confirm
specificity, we compared 3A4 staining of primary wild type and
Clec4d-deficient cells. Bone marrow-derived macrophage (BMM)-
lysates probed by Western blot revealed a band of expected size
(Fig. 1F) and analysis of murine PBL by flow cytometry using 3A4
(Fig. 1G) revealed staining of wild type but not Clec4d-deficient
cells. Thus 3A4 was used in all further experiments.
Characterization of mClec4d expression in the naı¨ve
mouse
To characterize the cellular expression of Clec4d in mice, we
firstly determined its mRNA expression profile in various tissues
by reverse transcription (RT) PCR (Fig. 2A). Similar to human
Clec4d [3], we found mClec4d transcript to be widely expressed in
tissues including liver, muscle, embryo, placenta, and lymph node
with strong expression in heart, spleen, lung, bone marrow, PBL,
and resident peritoneal macrophages. Based on these expression
patterns, we then characterized Clec4d protein expression on cells
within various transcript-positive and -negative tissues using our
novel mAB, 3A4.
We first analyzed Clec4d expression on cells harvested by peri-
toneal lavage from na¨ıve C57BL/6 mice, as the receptor was orig-
inally cloned from these cells by differential display PCR [2]. Con-
sistent with the mRNA expression profile (Fig. 2A and [2]) we
found Clec4d to be highly expressed on resident F4/80+CD11b+
peritoneal macrophages (Fig. 2B). In fact, expression of Clec4d on
these cells was the highest compared to all other cells/tissues ana-
lyzed in na¨ıve animals. Low levels of Clec4d expression were also
detected on the surface of Ly6G+ resident peritoneal neutrophils.
Within PBL, Clec4d was detected on Ly6G+ neutrophils and
F4/80+CD11b+ monocytes, while this receptor was not detectable
on the surface of eosinophils, T cells, B cells, and NK cells (Fig.
2C). Similarly, we found expression on splenic cells and in the
bone marrow, but no expression was detected on the surface of
cells in the lymph nodes despite observing Clec4d transcripts in
this tissue (Fig. 2A and Supporting Information Fig. 1A–C). Consis-
tent with our RT-PCR analysis, no significant expression of Clec4d
was observed in eye tissue (Fig. 2A and Supporting Information
Fig. 1D).
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Since Clec4d plays a crucial role in the innate immune response
to pulmonary Mycobacterial infections [9], we next character-
ized Clec4d expression in the lung. Unexpectedly, Clec4d was
not detected on the surface of SiglecF+ alveolar macrophages
and was only expressed at low levels on Ly6G+ neutrophils and
marginal levels on CD11b+F4/80+ macrophages (Fig. 2D). No
Clec4d expression was detected on the other pulmonary leuko-
cytes examined (Fig. 2D).
Modulation of Clec4d and Mincle expression on
macrophages
Expression of CTLRs can be modulated by inflammatory condi-
tions [1], so we next assessed expression of Clec4d on 4-day
thioglycollate-elicited peritoneal inflammatory cells. The highest
levels of Clec4d expression were detected on Ly6G+ neutrophils,
which represented less than <5% of the population at this time
point (Fig. 3A). We also detected Clec4d expression on elicited
CD11b+F4/80+ macrophages, but not at the levels seen on resi-
dent macrophages (compare to Fig. 2B). Moreover, isolation and
culturing these cells in vitro led to substantially reduced expres-
sion of this receptor (Fig. 3B), similar to what we had observed
with human cells [3]. Since Clec4d and Mincle are closely related
receptors, sharing the same ligand, we decided to include this
receptor in our investigation. Similarly to Clec4d, Mincle expres-
sion was absent on cultured thioglycollate-induced macrophages
(Fig. 3B). These expression levels formed the baseline for further
investigation of the effect of microbial stimuli on these plated
macrophages. Notably, there was a robust and dose-dependent
upregulation of Clec4d and Mincle on these cells in response to
BCG and heat-killedMycobacterium tuberculosis, as well as to fungi
and Gram− bacteria (Fig. 3C). Similar results were obtained for
BMM (Supporting Information Fig. 2).
These observations led us to investigate if expression of these
receptors on macrophages is modulated by defined biological
agents. We first tested a variety of TLR agonists, which lead to
substantial upregulation of Clec4d and Mincle expression on cul-
tured thioglycollate-elicited cells (Fig. 3D). In contrast, there was
no significant effect on Clec4d and Mincle expression following
stimulation with a variety of cytokines, although costimulation
with IFNγ significantly reduced LPS-induced receptor expression
(Fig. 3E). The very high Clec4d expression on resident
macrophages was retained after plating (Fig. 3F) and treatment
of these resident macrophages in vitro with TLR-agonists did not

Figure 1. Generation and characterization of novel mClec4d mono-
clonal antibodies. (A) Protein model (visualized using spdbv v4) of
Clec4d indicating the location of the KLH-conjugated peptide immuno-
gens (P160, blue, and P134, red, corresponding to amino acid (AA) 160–
176 and AA134-149, respectively). (B) BSA-conjugated peptide or BSA
alonewere coated on plates and detectedwith selected antibody clones
by ELISA to type their peptide specificity, as indicated. Data shown
are from one experiment with one sample per condition. (C) West-
ern blot of mClec4d-Fc (Clec4d) and mMincle-Fc (Mincle), separated by
SDS-PAGE under nonreducing (–β-ME) or reducing (+β-ME) conditions,
probed with the various antibody clones or anti-human IgG (α-hIgG),
as indicated. Blot from a single experiment. (D) Effect of various mAB
clones, as indicated, on GFP expression following BCG stimulation of
Clec4d-expressing reporter cells, unstimulated cells; ctrl mAB, unre-
lated control rat-anti mouse mAB. Data from one representative exper-
iment with one sample per condition. (E) Flow cytometry analysis of
NIH-3T3 cells expressing FcRγ andHA-tagged Clec4d or HA-taggedMin-
cle, stained with anti-HA, biotinylated-3A4 (3A4_bio), or isotype con-
trols, as indicated. Data are from a single experiment. (F) Western blot
of 50 μg RIPA-lysates from wild type and Clec4d−/− BMM stimulated
with LPS for 16 h, probed with 3A4 (top) and following stripping with
anti-GAPDH (bottom). Data from a single experiment. (G) Flow cytomet-
ric analysis of PBL fromwild type and Clec4d−/− mice, stained with 3A4.
Plots are representative of three experiments.
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Figure 2. Clec4d is expressed on myeloid cells. (A) RT-PCR analysis of Clec4d expression in cells and tissues, as indicated. GAPDH served as a
housekeeping control. Data from a single experiment. (B–D) Representative flow cytometry plots of Clec4d protein expression on (B) resident
peritoneal cells, (C) PBL, and (D) lung. (C) An example of the gating strategies used is shown for PBL. Gray filled histograms show IgG1-stained cells
while open blue histograms show Clec4d (3A4) stained cells. (B–D) Data shown are representative of at least three animals representative of at
least two experiments performed.
significantly change Clec4d expression, although there was a slight
but significant reduction upon treatment with zymosan (Fig. 3G).
Clec4d expression is coregulated with Mincle, but not
Dectin-2
Recent papers have suggested that Clec4d forms functional het-
erodimers with other CTLRs, particularly Mincle [7] and Dectin-2
[6]. To explore this in more detail, we made use of the mouse
fibroblast cell line NIH-3T3 in which Clec4d is retained intracel-
lularly [3] and retrovirally cotransduced these cells with FcRγ
along withMincle or Dectin-2. In agreement with previous reports,
we found that cotransduction with FcRγ alone was able to pro-
mote moderate levels of Clec4d surface expression (Fig. 4A) [5].
Strikingly, however, additional cotransduction of Mincle, but not
Dectin-2, led to a substantial increase of Clec4d surface expression
on these cells (Fig. 4A) while total Mincle and Dectin-2 protein
levels were comparable (Fig. 4A and Supporting Information Fig.
3A). This suggests that regulation of surface expression occurs at
a posttranslational level and shows that Clec4d requires Mincle,
but not Dectin-2, for optimal expression at the cell surface. This is
consistent with our observation that expression of Mincle mirrored
that of Clec4d in isolated thioglycollate–elicited macrophages and
in BMM following stimulation with microbial and TLR agonists
and cytokines (Fig. 3B–E).
Clec4d induces Mincle-expression in vivo
Our data suggest that Clec4d expression depends on Mincle,
but we have also previously shown that the induction of Mincle
requires Clec4d [5]. To investigate the effects of Clec4d-deficiency,
we examined Mincle expression on a variety of cells types in na¨ıve
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Figure 3. Modulation of Clec4d and Mincle expression by microbial
stimuli. (A–F) Flow cytometric analysis of receptor expression onmouse
peritoneal cells. (A) Peritoneal recruited cells 4 days after i.p. thioglycol-
late injectionwere analyzed for Clec4d expression (representative of>3
mice from two experiments). Plated thioglycollate-elicited peritoneal
macrophageswere analyzed for Clec4d andMincle expression under (B)
resting conditions,which indicates the baseline for further stimulations
(representative of >3 experiments) or after stimulation for 16 h with (C)
microbial agents: BCG, M. bovis BCG; MTB, M. tuberculosis; CaY, C. albi-
cans yeast; CaH, C. albicans hyphae; KPn, K. pneumoniae; Mal, Malassezia
(representative of a single experiment), (D) TLR agonists (pooled data
from two experiments performed in duplicates) or (E) cytokines (repre-
sentative of a single experiment performed in duplicates). (F) Resident
peritoneal cells were plated and (G) stimulated with TLR agonists for
16 h followed by Clec4d-expression analysis by flow cytometry (pooled
data from two experiments performed in duplicates). All data shown as
mean + SD for single experiments and mean + SEM for pooled exper-
iments of the indicate number of samples. Statistical significance was
determined by ANOVA and Dunnett’s multiple-comparison posttests;
*p < 0.05.
Figure 4. Clec4d forms a complex with Mincle, but not Dectin-2. (A)
NIH-3T3 fibroblast cells were transduced with FcRγ, Clec4d, and Mincle
or Dectin2, as indicated, followed by flow cytometric analysis of Clec4d
surface expression (left). Representative histograms of four indepen-
dent experiments performed on individual samples are shown: dotted
histograms, FcRγ alone; gray filled histograms, FcRγ with Clec4d; blue
and red histograms, Clec4d expression in the presence of Mincle and
Dectin-2, respectively. Receptor protein expression was confirmed by
Western blot using 25 μg of RIPA cell lysates probed with anti-HA or
anti-FcRγ followed by peroxidase conjugated anti-mouse or anti-rabbit,
respectively (right). (B) Thioglycollate elicited macrophages from wild
type or Clec4d−/− mice (n = 3) were stimulated as indicated and Clec4d
(3A4), Mincle (4A9), and Dectin-2 (11E4) expression assessed by flow
cytometry and represented as MFI. (C) Wild type or Clec4d−/− mice (n
= 3) were injected with immunomodulators intraperitoneally and cells
harvested 4 days later by peritoneal lavage followed by flow cytometric
analysis of CTLR expression. (B, C) Each symbol represents an individual
mouse and bars representmean+ SEM of single experiments represen-
tative of one (B) or two (C) experiments performed. Statistical signifi-
cance was determined by ANOVA and Dunnett’s multiple-comparison
posttests, *p < 0.05. (D) PBL from naı¨ve wild-type (black histograms),
Clec4d−/− (blue histograms), and Mincle−/− (red histograms) mice were
analyzed for receptor expression by flow cytometry. Histograms rep-
resent Clec4d (3A4) and Mincle (4A9) expression on Ly6G+ PMNs com-
pared to IgG1 isotype staining (gray filled histograms). Data shown are
froma single experiment. (E) BMM fromwild type (black bars), Clec4d−/−
(blue bars) or Mincle−/− mice (red bars) were left untreated or treated
with M. bovis BCG or LPS for 16 h and receptor expression assessed by
flow cytometry. Data are shown asmean+ SD from a single experiment
performed in duplicates.
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Figure 5. Coregulation of Clec4d and Mincle during pulmonary M. bovis BCG infection. CTLR expression on CD45+ pulmonary leukocytes in naı¨ve
wild type and Clec4d−/− mice and 48 h following infectionwithM. bovis BCGwere analyzed by flow cytometry. (A) CD45+ and (B) population-specific
cellular expression levels of Clec4d were determined by flow cytometry. Shown are pooled data from two independent experiments, n = 6–9 mice
per group from both experiments. (C) Representative histogram of Clec4d expression on alveolar macrophages following infection as above. Black
dotted histogram, wild-type naı¨ve; gray filled histogram, Clec4d−/− +BCG; solid black histogram, wild-type +BCG. (D) Expression levels of Mincle
on CD45+ cells. Shown are pooled data from three experiments, n = 9–15 mice per group. (E) Expression levels of Dectin-2 on CD45+ cells. Shown
are pooled data from three experiments, n = 9–15 mice per group in total. (A, D, E) Each symbol represents an individual mouse and bars represent
mean + SEM. Statistical significance was determined by Student’s t-test, *p < 0.05, ***p < 0.001.
wild type and in Clec4d-deficient mice. Notably, Mincle expres-
sion closely mirrored Clec4d-expression in resident peritoneal
macrophages, and was lost in the absence of Clec4d (Support-
ing Information Fig. 3B). As these data suggest an interdepen-
dent coregulation of both receptors, but not Dectin-2, we further
examined this phenomenon in isolated primary macrophages in
vitro and on inflammatory cells in vivo. Thioglycollate-elicited
macrophages from C57BL/6 wild-type and Clec4d−/− mice were
stimulated withM. bovis BCG and LPS in vitro and receptor expres-
sion of Clec4d, Mincle, and Dectin-2 analyzed by flow cytometry.
All treatments led to a robust upregulation of expression of these
three receptors on wild-type cells (Fig. 4B). However, stimulated
Clec4d−/− macrophages failed to robustly induce Mincle, while
expression of Dectin-2 was largely unaffected (Fig. 4B). Similarly,
in Clec4d−/− mice in vivo, Mincle expression was impaired on
thioglycollate-, LPS-, and BCG-induced inflammatory peritoneal
cells at 1 and 4 days after i.p. injection (Fig. 4C and Support-
ing Information Fig. 3C). In contrast, Clec4d-deficiency had no
effect on Dectin-2 expression (Fig. 4C and Supporting Information
Fig. 3C).
Mincle is required for Clec4d surface expression
We have shown that Clec4d is required to induce Mincle expres-
sion in vitro and in vivo. Yet, our initial experiments coexpress-
ing Mincle and Clec4d in NIH-3T3 cells (Fig. 4A) suggested that
Mincle was reciprocally required for the surface expression of
Clec4d. To investigate this interdependence further, we made
use of Mincle-deficient mice. As we had observed on resident
peritoneal macrophages (Supporting Information Fig. 3B), the
expression of Mincle and Clec4d on peripheral blood neutrophils
or CD11b+ bone marrow cells from na¨ıve mice closely mirrored
each other. As before, Mincle expression was lost in the absence
of Clec4d (Fig. 4D and Supporting Information Fig. 4) and con-
versely, Clec4d expression was absent on Mincle-deficient cells
(Fig. 4D and Supporting Information Fig. 4). Since Mincle was
essential for Clec4d expression under na¨ıve conditions, we fur-
ther investigated whether Mincle was required for Clec4d upreg-
ulation following microbial challenge. Wild-type BMM robustly
upregulated Clec4d and Mincle expression in response to BCG
and LPS (Fig. 4E). However, the lack of Mincle resulted in a fail-
ure to significantly upregulate Clec4d and vice versa (Fig. 4E).
Taken together, these data demonstrate that Mincle and Clec4d
are coregulated and dependent on each other, forming a func-
tional receptor complex required for surface expression.
Clec4d expression during pulmonary mycobacterial
infection
We recently discovered that Clec4d plays a key role in anti-
mycobacterial immunity by facilitating bacterial clearance by pul-
monary leukocytes [9]. As the levels of Clec4d expression on pul-
monary leukocytes were relatively low in na¨ıve mice (Fig. 2D),
expression of this receptor in the lung was examined following
infection withM. bovis BCG. Two days post intratracheal infection
with BCG, there was a significant increase in total Clec4d expres-
sion on CD45+ pulmonary leukocytes compared to uninfected con-
trol mice (Fig. 5A). In fact, infection with BCG led to increases
in Clec4d expression on all myeloid cell populations examined,
including a significant increase on alveolar macrophages (Fig. 5B,
C and Supporting Information Fig. 5). Similarly, expression of
Mincle was robustly induced in wild-type mice following infection
with BCG (Fig. 5D). In contrast to our results with peritoneal cells
(Figs. 3 and 4), expression of Mincle was detectable on pulmonary
cells isolated from na¨ıve Clec4d−/− mice (Fig. 5D). However, in
contrast to wild-type mice, infection of the knockout animals with
BCG did not lead to an increased expression of Mincle (Fig. 5D).
Correspondingly, plated alveolar macrophages from na¨ıve mice
required coexpression of Clec4d to robustly upregulate Mincle in
response to BCG and LPS in vitro (Supporting Information Fig. 5).
Expression of Dectin-2 was unaltered following BCG infection in
wild-type and Clec4d-deficient mice (Fig. 5E).
Discussion
There is increasing appreciation that CTLR play key roles in pro-
tective immunity to a variety of pathogens [10]. Notably, mice
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lacking the downstream signaling adaptor, CARD9, are extremely
susceptible to infections with fungi and Mycobacteria [11]. Sev-
eral CTLRs have subsequently been implicated in mycobacterial
recognition including Mincle, Dectin-2, and Clec4d [9, 10, 12].
Although Mincle-deficiency led to increased M. bovis BCG lung
burdens, of these receptors, only Clec4d has so far been found
to play a nonredundant role during infection in vivo resulting
in significant mortality [9, 13]. Thus given the importance of
this receptor, and the mouse as a model of mycobacterial infec-
tion [14], we characterized the expression of Clec4d in na¨ıve
mice, under inflammatory conditions and during mycobacterial
infection.
In na¨ıve animals, we detected Clec4d expression on myeloid
cells in a variety of tissues, particularly on cells of the mono-
cyte/macrophage and neutrophil lineages. Similar expression pro-
files have been described in human and rat [3, 4]. The high-
est levels of expression were detected on the surface of resident
peritoneal macrophages, consistent with transcriptional analysis
performed during the initial characterization of the receptor [2].
Surprisingly given its role in anti-mycobacterial immunity, and in
contrast to rat [4], Clec4d was poorly expressed by pulmonary
myeloid cells and not detectable on alveolar macrophages. How-
ever, pulmonary infection with M. bovis BCG led to upregulation
of this receptor on the surface of pulmonary leukocytes includ-
ing alveolar macrophages. These increases in Clec4d expression
levels within the lung were lower than expected, albeit signifi-
cant for alveolar macrophages. However, we showed previously
that a complete loss of Clec4d (and therefore potentially Min-
cle) resulted in a profound defect in the innate response toward
mycobacterial infection in a mouse model, underlining the impor-
tance and relevance of Clec4d expression in this tissue [9]. Impor-
tantly, this increased Clec4d expression during infection is reflec-
tive of the transcriptional upregulation of this receptor that we
had observed in patients suffering from pulmonary tuberculosis
[9].
The induction of peritoneal inflammation using thioglycollate,
LPS or M. bovis BCG in our mouse models led to the recruitment
of Clec4d-expressing inflammatory macrophages and neutrophils.
Culture of inflammatory macrophages in vitro, however, led to
a complete loss of Clec4d expression, similar to effect observed
following culture of human monocytes [3]. Stimulation of the
cultured murine cells with a variety of intact and purified micro-
bial agonists, but not with cytokines, was able to increase surface
expression of Clec4d. In contrast, expression of the receptor on
resident macrophages was largely unaffected following culture
in vitro or following stimulation with microbial agonists. These
observations suggest that the mechanisms involved in the regula-
tion of Clec4d-expression differ between resident and inflamma-
tory macrophages. While the induction of this receptor on inflam-
matory cells makes physiological sense, in terms of its role in
antimicrobial immunity, why resident macrophages have such a
high level of expression is currently unclear. It is possible that
like many other C-type lectins, Clec4d recognizes endogenous lig-
and(s) and plays a homeostatic role that has yet to be determined
[1].
Clec4d has been shown to form functional heteromeric com-
plexes with Dectin-2 and Mincle [6, 7]. Clec4d has also previously
been shown to be required for the induction of Mincle following
stimulation with TDM [5], through CARD9-dependent NFκB acti-
vation [15]. While our data clearly support an interaction between
Clec4d and Mincle, we found no evidence that Dectin-2 was nec-
essary for surface expression of Clec4d, nor was expression of
Dectin-2 changed in the absence of Clec4d. Mincle, but not Dectin-
2, was able to transport Clec4d to the surface of transfected cells.
Furthermore, Mincle was essential for steady-state Clec4d expres-
sion on primary cells and its upregulation in response to microbial
stimuli in vitro. This is corroborated by a recent study showing
that Mincle-deficient bone marrow-derived DCs fail to upregulate
Clec4d-expression in response to LPS [16]. Moreover, we found
that the expression of Mincle, but not Dectin-2, was regulated in a
manner similar to that of Clec4d, following microbial stimulation
in vitro and in vivo. In addition, deficiency of Clec4d correlated
with a loss of Mincle expression on peritoneal inflammatory cells,
while there was no effect on expression of Dectin-2. Intriguingly,
Mincle was expressed in the na¨ıve lung in Clec4d-deficient ani-
mals, consistent with our observation that surface expression of
this receptor only requires the FcRγ adaptor. However, in the
absence of Clec4d, expression of Mincle is not upregulated follow-
ing mycobacterial infection. Thus our data suggest that there is an
interdependent coregulation of both receptors for expression at
the cell surface. As this interdependence is likely to play an impor-
tant role in anti-mycobacterial immunity, future work should be
aimed at determining the underlying mechanisms.
Materials and methods
Animals
C57BL/6 and Clec4d−/− [3] mice, sex, and age matched as
required, were obtained from specific pathogen-free facilities at
the University of Aberdeen. All animal experiments were in agree-
ment with the animal care and welfare protocols approved by the
University of Aberdeen (project licences 60/4007 and 70/8073).
Strains, growth conditions, and infections
M. bovis BCG strain Pasteur and a GFP-expressing derivative [17]
were grown on Middlebrook 7H10 agar plates containing 10%
ADC (BD), or Middlebrook 7H9 broth containing 10% ADC and
0.05% Tween 80 (Sigma). For in vitro stimulation experiments, E.
coli and K. pneumoniae were grown in nutrient broth, C. albicans
in yeast-peptone-dextrose broth overnight at 37ºC. Fungal hyphae
were induced in PBSwith 10% foetal bovine serum (Gibco) at 37ºC
until hyphal morphology was observed microscopically, usually
within 4 h.
To assess cell recruitment and receptor expression during pul-
monary infection, 5 × 105 colony forming units BCG were admin-
istered intratracheally (i.t.) to anesthetized mice. Bronchoalveolar
C© 2015 The Authors. European Journal of Immunology published by
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lavages were performed 2 days after infection with PBS containing
5 mM EDTA (Gibco). Sterile peritonitis was induced by injecting
1 mL thioglycollate (BD), 1 × 107 heat-killed BCG or 1 μg LPS
(Sigma) i.p. and cells were harvested by peritoneal lavage with
PBS 5 mM EDTA after 1-4 days, as stated in the text.
Cells, cell lines, and stimulation
NFAT-GFP reporter cells, cotransfected with mClec4d and FcRγ,
were described previously [5]. NIH-3T3 mouse fibroblast cell lines
coexpressing FcRγ, mClec4d HA, and mMincle HA or mDectin-
2 his6 or mDectin-2 HA were generated by retroviral transduc-
tion as described previously [3, 18]. Receptor expression was con-
firmed by Western blot following conventional protocols using
antibodies against the HA-tag (HA.11 clone 16B12, Covance)
and FcRγ (06-727, Millipore) followed by appropriate peroxidase-
conjugated secondary antibodies (Jackson). Cell lines were gen-
erated at least twice and used as nonclonal populations to reduce
founder effects. BMMs were generated from murine bone marrow
cells by addition of L929 supernatant (M-CSF), as described previ-
ously [19]. The effect of TLR agonists (Invivogen), cytokine treat-
ment (R&D, Miltenyi), and zymosan (Sigma) on receptor expres-
sion was performed as described previously [20, 21]. Generally,
cells were seeded at 4 × 105 per well in 24-well plates and cul-
tured overnight, followed by three washes before the addition of
stimuli for 16 h. Then, cells were analyzed by flow-cytometry, as
described below. For each treatment cells were stained with anti-
receptor mABs and the respective isotype controls and fold change
of expression calculated as described before [21]: the mean flu-
orescence of isotype controls were subtracted from the mean flu-
orescence of anti-receptor stained cells and the resulting mean
fluorescence of treated samples divided by the mean fluorescence
of the untreated controls.
RT-PCR analysis
Template for RT PCR was a commercial tissue cDNA panel (Clon-
tech). For bone marrow, blood, and peritoneal macrophages,
mRNA was isolated using TRI reagent (Applied Biosystems)
and RNeasy kit (Qiagen), followed by cDNA synthesis with
SuperScript III First-Strand SuperMix (Invitrogen) according to
manufacturers’ instructions. Clec4d mRNA expression was ana-
lyzed using standard PCR protocols with primers mClec4d F
(5’AGGTACTTGGACCTGCTGTCCTGTAGC), mClec4d R (5’TCC-
CCCTTTTCCCAGAATACCGTGTG), and Clontech GAPDH or
mGAPDH F (5’CCAGGTTGTCTCCTGCGACTT) and mGAPDH R
(5’CCTGTTGCTGTAGCCGTATTCA) primers.
Generation of monoclonal antibodies
To generate Clec4d mABs, Sprague Dawley rats were immunized
with KLH-conjugated Clec4d peptides (GenScript), as described
in the text, splenocytes harvested, and fused to Y3 rat myeloma
cells as described before [22]. Hybridoma supernatants were
screened by ELISA using BSA-conjugated Clec4d peptides and by
flow cytometry using Clec4d transduced cell lines. Monoclonality
was attained by limiting dilution. Detection of purified Clec4d-Fc
and Mincle-Fc or endogenous Clec4d and GAPDH (Clone mAb-
cam 9484) in BMM by Western blot followed conventional proto-
cols using appropriate HRP-linked secondary antibodies (Jackson)
[3, 18].
Flow cytometry analysis
Receptor expression was analyzed by flow cytometry using BD
LSRII, Fortessa, and Array flow cytometers as described previ-
ously [3] and analyzed using FlowJo vX.0.6. Cell populations
were identified using the following antibodies purchased from
BD or Abd Serotec: CD45 (104), CD11b (M1/70), CD11c (HL3),
Ly-6G (1A8), SiglecF (E50-2440), F4/80 (Cl:A3-1), CD3 (145-
2C11), CD4 (RM4-5), CD8 (53-6.7), NK1.1 (PK163), CD49b
(DX5), B220 (RA3-6B2), 7/4 (MCA771). HA-tagged receptors
were detected using Mouse anti-HA.11 (Covance) and anti-mouse
PE (Jackson). We used in-house developed antibodies against
Clec4d (3A4, described in the text), Mincle (Clone 4A9) [5],
and Dectin-2 (Clone 11E4) [23] in conjunction with anti-rat
PE/Cy5 secondary antibodies (Jackson) or streptavidin APC/PE-
CF594 (Invitrogen/BD). Monocytes/macrophages were defined
as CD11b+/F4/80+, alveolar macrophages as CD11c+/SiglecF+,
PMN as CD11b+/Ly6G+, eosinophils as SSChi/SiglecF+, dendritic
cells as CD11c+, lymphocytes were defined by SSC and expres-
sion of CD3 (T cells), B220 (B cells), and NK1.1 or CD49b (NK
cells).
Tissues were harvested and dissociated in the presence of lib-
erase and DNase (Roche) (lung, eye), or directly passed through
cell strainers (spleen, bone marrow, lymph nodes), red blood
cells lysed using FACS Lyse (BD), followed by FACS analysis per-
formed as described previously [3]. Briefly, cells were stained in
FACS wash (PBS with 0.5% BSA, 10 mM EDTA, 2 mM sodium
azide) with 5% rabbit serum (FACS block) and where appropriate
4 μg/mL 2.4G2 at 4ºC. Following washing, cells were incubated
with the respective secondary antibody in FACS block at 4ºC. After
further washing, cells were fixed with 1% paraformaldehyde in
FACS wash and analyzed by flow cytometry.
Statistics
Statistical analyses were performed using ANOVA and Dunnett’s
multiple-comparison post tests or Student’s t-test, as appropriate,
with GraphPad Prism v5.04. * = p <0.05, *** = p < 0.001.
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